IBDEI1KP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27925,0)
 ;;=V25.09^^162^1790^14
 ;;^UTILITY(U,$J,358.3,27925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27925,1,4,0)
 ;;=4^V25.09
 ;;^UTILITY(U,$J,358.3,27925,1,5,0)
 ;;=5^Contraceptive Counseling
 ;;^UTILITY(U,$J,358.3,27925,2)
 ;;=^87608
 ;;^UTILITY(U,$J,358.3,27926,0)
 ;;=V25.9^^162^1790^15
 ;;^UTILITY(U,$J,358.3,27926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27926,1,4,0)
 ;;=4^V25.9
 ;;^UTILITY(U,$J,358.3,27926,1,5,0)
 ;;=5^Contraceptive Management
 ;;^UTILITY(U,$J,358.3,27926,2)
 ;;=^276356
 ;;^UTILITY(U,$J,358.3,27927,0)
 ;;=620.2^^162^1790^40
 ;;^UTILITY(U,$J,358.3,27927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27927,1,4,0)
 ;;=4^620.2
 ;;^UTILITY(U,$J,358.3,27927,1,5,0)
 ;;=5^Ovarian Cyst
 ;;^UTILITY(U,$J,358.3,27927,2)
 ;;=Ovarian Cyst^87319
 ;;^UTILITY(U,$J,358.3,27928,0)
 ;;=595.9^^162^1790^16
 ;;^UTILITY(U,$J,358.3,27928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27928,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,27928,1,5,0)
 ;;=5^Cystitis, Unspec
 ;;^UTILITY(U,$J,358.3,27928,2)
 ;;=Cystitis, Unspec^30304
 ;;^UTILITY(U,$J,358.3,27929,0)
 ;;=626.8^^162^1790^17
 ;;^UTILITY(U,$J,358.3,27929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27929,1,4,0)
 ;;=4^626.8
 ;;^UTILITY(U,$J,358.3,27929,1,5,0)
 ;;=5^Dysfunctional Uterine Bleeding
 ;;^UTILITY(U,$J,358.3,27929,2)
 ;;=^87521
 ;;^UTILITY(U,$J,358.3,27930,0)
 ;;=625.3^^162^1790^18
 ;;^UTILITY(U,$J,358.3,27930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27930,1,4,0)
 ;;=4^625.3
 ;;^UTILITY(U,$J,358.3,27930,1,5,0)
 ;;=5^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,27930,2)
 ;;=Dysmenorrhea^37592
 ;;^UTILITY(U,$J,358.3,27931,0)
 ;;=625.0^^162^1790^19
 ;;^UTILITY(U,$J,358.3,27931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27931,1,4,0)
 ;;=4^625.0
 ;;^UTILITY(U,$J,358.3,27931,1,5,0)
 ;;=5^Dyspareunia
 ;;^UTILITY(U,$J,358.3,27931,2)
 ;;=Dyspareunia^37604
 ;;^UTILITY(U,$J,358.3,27932,0)
 ;;=788.1^^162^1790^21
 ;;^UTILITY(U,$J,358.3,27932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27932,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,27932,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,27932,2)
 ;;=Dysuria^37716
 ;;^UTILITY(U,$J,358.3,27933,0)
 ;;=621.0^^162^1790^22
 ;;^UTILITY(U,$J,358.3,27933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27933,1,4,0)
 ;;=4^621.0
 ;;^UTILITY(U,$J,358.3,27933,1,5,0)
 ;;=5^Endometrial Polyps
 ;;^UTILITY(U,$J,358.3,27933,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,27934,0)
 ;;=617.9^^162^1790^23
 ;;^UTILITY(U,$J,358.3,27934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27934,1,4,0)
 ;;=4^617.9
 ;;^UTILITY(U,$J,358.3,27934,1,5,0)
 ;;=5^Endometriosis, Site Unsp
 ;;^UTILITY(U,$J,358.3,27934,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,27935,0)
 ;;=704.1^^162^1790^28
 ;;^UTILITY(U,$J,358.3,27935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27935,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,27935,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,27935,2)
 ;;=Hirsutism^57407
 ;;^UTILITY(U,$J,358.3,27936,0)
 ;;=V07.4^^162^1790^29
 ;;^UTILITY(U,$J,358.3,27936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27936,1,4,0)
 ;;=4^V07.4
 ;;^UTILITY(U,$J,358.3,27936,1,5,0)
 ;;=5^Hormone Replacement Therapy
 ;;^UTILITY(U,$J,358.3,27936,2)
 ;;=^295199
 ;;^UTILITY(U,$J,358.3,27937,0)
 ;;=625.6^^162^1790^31
 ;;^UTILITY(U,$J,358.3,27937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27937,1,4,0)
 ;;=4^625.6
 ;;^UTILITY(U,$J,358.3,27937,1,5,0)
 ;;=5^Incontinence, Stress
 ;;^UTILITY(U,$J,358.3,27937,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,27938,0)
 ;;=628.9^^162^1790^32
 ;;^UTILITY(U,$J,358.3,27938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27938,1,4,0)
 ;;=4^628.9
 ;;
 ;;$END ROU IBDEI1KP
